Investigating how short sleep affects diabetes risk through biomarkers
Biomarkers of Habitual Short Sleep and Related Cardiometabolic Risk
This study is looking at how not getting enough sleep might increase the chances of developing type 2 diabetes, especially for adults whose jobs or lifestyles keep them from sleeping well, and it hopes to find ways to improve sleep and reduce this risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11199505 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between habitual short sleep durations and the risk of developing type 2 diabetes. It aims to identify molecular biomarkers that link short sleep with increased diabetes risk, particularly in adults who experience short sleep due to their occupations or lifestyles. By studying these biomarkers, the research seeks to uncover the mechanisms behind this risk and evaluate whether extending sleep can reverse it. Participants may undergo assessments to measure their sleep patterns and related biological markers.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who regularly sleep less than the recommended 7 hours per night, particularly those in high-risk occupations like medical personnel, military, and emergency responders.
Not a fit: Patients who consistently get adequate sleep and do not have risk factors for type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing type 2 diabetes in individuals who do not get enough sleep.
How similar studies have performed: Previous research has shown promising results in understanding the link between sleep duration and diabetes risk, but this study aims to explore this connection in a real-world context, making it a novel approach.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Depner, Christopher Michael — University of Utah
- Study coordinator: Depner, Christopher Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.